Collectively, these findings indicate that the abnormal O-GlcNAc modification of eNOS is crucial in the development of endothelial dysfunction caused by high salt levels, and targeting this modification via OGT inhibition may represent a potential therapeutic strategy to alleviate salt-related vascular damage. The gene discussed is NOS3; the disease is endothelial dysfunction.